Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2).
Advances in therapy
View this publicationAdvances in therapy
View this publicationJournal of fungi (Basel, Switzerland)
View this publicationMolecular neurodegeneration
View this publicationCurrent biology : CB
View this publicationResearch and practice in thrombosis and haemostasis
View this publicationNature
View this publicationAging cell
View this publicationGlia
View this publicationNature communications
View this publicationAmerican journal of respiratory cell and molecular biology
View this publication